Market Overview
For the Quarter Ending September 2025
Clobetasol Propionate Price in North America
In United States, Clobetasol Propionate Price Index rose in Q3 2025, driven by surging API costs and new import tariffs.
Production costs for Clobetasol Propionate increased due to surging Active Pharmaceutical Ingredient costs in July 2025.
New US tariffs on pharmaceutical imports, effective August 2025, significantly elevated Clobetasol Propionate input costs.
Demand for Clobetasol Propionate supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
The pharmaceutical supply chain faced Q3 2025 complications from logistical issues, risking Clobetasol Propionate shortages.
General inflation, at 3.0% CPI in September 2025, contributed to higher operational costs for manufacturers.
Wholesale electricity prices continued rising across the US in 2025, impacting Clobetasol Propionate manufacturing expenses.
Pharmaceutical and Biotechnology market sentiment showed an upward trajectory in Q3 2025, with FDA drug approvals surging.
Why did the price of Clobetasol Propionate change in September 2025 in North America?
Active Pharmaceutical Ingredient costs surged in July 2025, compounded by new US import tariffs from August 2025.
Logistical issues in the pharmaceutical supply chain constrained availability, risking Clobetasol Propionate shortages in Q3 2025.
Strong consumer spending, with retail sales up 5.42% and unemployment at 4.3% in September 2025, supported demand.
Clobetasol Propionate Price in APAC
In China, the Clobetasol Propionate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices and soft domestic demand.
Clobetasol Propionate production costs trended lower in Q3 2025, with the Producer Price Index falling 2.3% year-on-year in September 2025.
The demand outlook for Clobetasol Propionate was challenged by a 0.3% year-on-year decline in CPI in September 2025.
Consumer confidence remained low at 89.6 in September 2025, alongside a 5.2% unemployment rate, impacting healthcare spending.
The Manufacturing Index was contracting in September 2025, signaling reduced industrial activity affecting Clobetasol Propionate supply.
Industrial production grew 6.5% year-on-year in September 2025, supporting underlying capacity for pharmaceutical manufacturing.
Global chemical overcapacity persisted in 2025, contributing to elevated inventories and downward pressure on general chemical input costs.
Demand for pharmaceutical products was bolstered by an aging population and rising chronic diseases in China during Q3 2025.
Why did the price of Clobetasol Propionate change in September 2025 in APAC?
Producer Price Index fell 2.3% year-on-year, reducing Clobetasol Propionate production costs.
Consumer Price Index declined 0.3% year-on-year, indicating soft domestic demand.
Global chemical overcapacity and contracting Manufacturing Index pressured prices downward.
Clobetasol Propionate Price in Europe
In Germany, the Clobetasol Propionate Price Index remained stable quarter-over-quarter in Q3 2025, balancing various cost and demand factors.
Clobetasol Propionate production costs were influenced by a -1.7% year-over-year PPI decline, despite a 2.4% CPI in September 2025.
Demand for Clobetasol Propionate was bolstered by a significant uplift in German pharmaceutical production in July 2025.
The Clobetasol Propionate demand outlook is supported by an aging population and increasing chronic conditions in Q3 2025.
Germany's Manufacturing Index was contracting in Q3 2025, signaling a broader industrial sector slowdown.
Industrial production decreased by 1.0% year-over-year in September 2025, impacting non-API input costs.
Retail sales increased by 0.2% year-over-year in September 2025, indicating stable consumer purchasing power.
High electricity prices in Germany during Q3 2025 challenged industrial competitiveness and production expenses.
The Clobetasol Propionate price forecast suggests continued stability, balancing cost pressures with steady pharmaceutical demand.
Why did the price of Clobetasol Propionate change in September 2025 in Europe?
Producer prices for intermediate goods declined in Q3 2025, reducing Clobetasol Propionate manufacturing costs.
German pharmaceutical production increased significantly in July 2025, supporting Clobetasol Propionate supply.
Stable retail sales, up 0.2% year-over-year in September 2025, maintained consumer affordability for related products.
view historical insights
How We Can Help
ChemAnalyst: Your Source for Real-Time Market News, Weekly Price Updates
Stay ahead of the competition with ChemAnalyst, the premier provider of
actionable market news. We offer real-time updates on prices, tracking and
reporting pricing trends, market news, and demand & supply for over 450
commodities.
Why choose ChemAnalyst? We go beyond just providing prices - we give you the
insights behind them. Our expert analysts not only deliver accurate price
data but also explain the exact reasons why prices have gone up or down.
This knowledge helps you make informed decisions and understand market
dynamics.
Planning your purchase at the right timing is crucial, and that's why we
provide price forecasts. Our forecasts help you anticipate market movements,
enabling you to optimize your procurement strategy and maximize cost
savings. Additionally, we track plant shutdowns to assess any risks
associated with supply disruptions. By keeping you informed about potential
disruptions, we empower you to proactively manage your supply chain and
mitigate any potential issues.
Our Analysts team comprises chemical engineers and experts with strong
backgrounds in economics, manufacturing, supply chain, and trading. With
offices in Houston, Cologne, and New Delhi, we provide a comprehensive view
of the global market. Our ground teams are based out of more than 50+ major
trading ports such as Houston, Shanghai, Busan, Rotterdam, Jebel Ali,
Antwerp, Hamburg, and more. This ensures that we have firsthand information
and insights on market activities, allowing us to deliver accurate and
timely reports.
Don't miss out on valuable insights! Keep your procurement teams informed and
empowered with ChemAnalyst's unparalleled expertise.
Subscribe ChemAnalyst today for the latest market news and stay on top of
your game.
Product Description
Clobetasol Propionate is a potent synthetic corticosteroid, belonging to the class of glucocorticoid steroid compounds. Chemically it is a halogenated 17-propionate derivative of a steroid nucleus (molecular formula C₂₅H₃₂ClFO₅, CAS 25122-46-7). The compound is typically produced via multi-step organic synthesis involving steroidal precursors, with careful introduction of the chlorine and fluorine substituents, and subsequent esterification to form the propionate ester. The final product is isolated as a fine crystalline or powdered API under controlled conditions to meet pharmacopeial purity standards (e.g. USP / BP / EP). Physically/chemically, Clobetasol Propionate is a stable, lipophilic steroid: its ester linkage increases lipid solubility, which aids in its penetration into biological membranes (skin). Its chemical stability under typical formulation conditions, combined with its high potency, makes it highly effective. Functionally, it is valued for strong anti-inflammatory, immunosuppressive and antipruritic (anti-itch) effects — properties typical of high-potency corticosteroids. These attributes make Clobetasol Propionate a powerful therapeutic agent when used appropriately. Because of these properties, Clobetasol Propionate is primarily used in dermatology. Its major application areas include topical treatments (creams, ointments, lotions, gels) for severe corticosteroid-responsive dermatoses — such as psoriasis, eczema, dermatitis, and other inflammatory or allergic skin conditions. In its API form, it supplies pharmaceutical manufacturers with the active substance required for formulating high-potency topical medications under rigorous quality and regulatory standards.
